Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Receivables (2019 - 2022)

NovaBridge Biosciences (NBP) has disclosed Receivables for 4 consecutive years, with $4.7 million as the latest value for Q4 2022.

  • Quarterly Receivables fell 25.78% to $4.7 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Dec 2022, down 25.78% year-over-year, with the annual reading at $6.4 million for FY2021, 88.35% down from the prior year.
  • Receivables for Q4 2022 was $4.7 million at NovaBridge Biosciences, down from $6.4 million in the prior quarter.
  • The five-year high for Receivables was $36.1 million in Q4 2020, with the low at $2.9 million in Q4 2019.
  • Average Receivables over 4 years is $12.5 million, with a median of $5.6 million recorded in 2021.
  • The sharpest move saw Receivables surged 1163.44% in 2020, then tumbled 82.3% in 2021.
  • Over 4 years, Receivables stood at $2.9 million in 2019, then soared by 1163.44% to $36.1 million in 2020, then crashed by 82.3% to $6.4 million in 2021, then fell by 25.78% to $4.7 million in 2022.
  • According to Business Quant data, Receivables over the past three periods came in at $4.7 million, $6.4 million, and $36.1 million for Q4 2022, Q4 2021, and Q4 2020 respectively.